Columbus, Ohio 43210


Purpose:

The purpose of this study is to investigate new therapies for advanced lung disease.


Study summary:

This research study is being conducted to learn about the progression and cause of lung disease. By agreeing to be a part of this study, you will allow the lung tissue which would normally have been discarded after your procedure, to be used for research purposes to allow us to understand more about your condition which may potentially lead to novel treatments and therapeutics. For this study, the investigators will isolate specific cells from the lung tissue and measure cellular, molecular and genetic mechanisms responsible for regulating lung disease. No other type of research will be performed on these samples nor will the samples be given to other investigators for unrelated research.


Criteria:

Inclusion Criteria: - any one on lung transplant list Exclusion Criteria: - HIV positive


NCT ID:

NCT02369575


Primary Contact:

Principal Investigator
Megan Ballinger
Ohio State University

Megan Ballinger
Phone: 614-292-6578
Email: megan.ballinger@osumc.edu


Backup Contact:

N/A


Location Contact:

Columbus, Ohio 43210
United States

Megan Ballinger
Email: megan.ballinger@osumc.edu

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: November 19, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.